PanGen Biotech Inc.

KOSDAQ:A222110 Stock Report

Market Cap: ₩70.9b

PanGen Biotech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jaeseung Yoon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership3.1%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Is PanGen Biotech (KOSDAQ:222110) A Risky Investment?

Aug 13
Is PanGen Biotech (KOSDAQ:222110) A Risky Investment?

Is PanGen Biotech (KOSDAQ:222110) Using Debt In A Risky Way?

Feb 17
Is PanGen Biotech (KOSDAQ:222110) Using Debt In A Risky Way?

PanGen Biotech's (KOSDAQ:222110) Stock Price Has Reduced 33% In The Past Three Years

Dec 26
PanGen Biotech's (KOSDAQ:222110) Stock Price Has Reduced 33% In The Past Three Years

CEO

Jaeseung Yoon (63 yo)

no data

Tenure

Jaeseung Yoon is Co-Founded PanGen Biotech Inc. and serves as President & Co-Chief Executive Officer at PanGen Biotech Inc. and served as Co-President & Chief Executive Officer.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:31
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PanGen Biotech Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jae KimDAOL Investment & Securities Co., Ltd.
Bora ChungKorea Investment & Securities Co., Ltd.